Abstract
Cancer is a disease which represents one of the leading causes of death in the world. Surgery, chemotherapy, radiotherapy, and combination of these strategies are the most common types of treatment. However, there are problems of efficacy, toxicity, and nonspecificity associated with the traditional treatment methods. Therefore, novel strategies are needed to be developed for safe and effective treatment of cancer with minimal side effects. In recent decades, various nanoparticles for drug delivery applications have been designed to overcome these problems and they have presented great potential for cancer therapy due to their chemical and physical characteristics and biological attributes. Nanoparticles are able to deliver the anticancer agent more efficiently to the tumor site with improved therapeutic efficiency and reduced systemic side effects. This chapter aims to revise different kinds of nanoparticles as anticancer drug delivery systems.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abadeer NS, Murphy CJ (2016) Recent progress in cancer thermal therapy using gold nanoparticles. J Phys Chem C 120(9):4691–4716
Abd-Elsalam K, Mohamed AA, Prasad R (2019) Magnetic nanostructures: environmental and agricultural applications. Springer, New York. ISBN 978-3-030-16438-6. https://www.springer.com/gp/book/9783030164386
Adams ML, Lavasanifar A, Kwon GS (2003) Amphiphilic block copolymers for drug delivery. J Pharm Sci 92(7):1343–1355
Aftab S, Shah A, Nadhman A, Kurbanoglu S, Ozkan SA, Dionysiou DD, Shukla SS, Aminabhavi TM (2018) Nanomedicine: an effective tool in cancer therapy. Int J Pharm 540(1–2):132–149
Aghebati-Maleki A, Dolati S, Ahmadi M, Baghbanzhadeh A, Asadi M, Fotouhi A, Yousefi M, Aghebati-Maleki L (2020) Nanoparticles and cancer therapy: perspectives for application of nanoparticles in the treatment of cancers. J Cell Physiol 235:1962–1972
Ahlawat J, Henriquez G, Narayan M (2018) Enhancing the delivery of chemotherapeutics: role of biodegradable polymeric nanoparticles. Molecules 23(9):2157
Aziz N, Faraz M, Sherwani MA, Fatma T, Prasad R (2019) Illuminating the anticancerous efficacy of a new fungal chassis for silver nanoparticle synthesis. Front Chem 7:65. https://doi.org/10.3389/fchem.2019.00065
Barenholz Y (2012) Doxil (R) - the first FDA-approved nano-drug: lessons learned. J Control Release 160(2):117–134
Barth RF, Coderre JA, Vicente MGH, Blue TE (2005) Boron neutron capture therapy of cancer: current status and future prospects. Clin Cancer Res 11(11):3987–4002
Bayda S, Hadla M, Palazzolo S, Riello P, Corona G, Toffoli G, Rizzolio F (2018) Inorganic nanoparticles for Cancer therapy: a transition from lab to clinic. Curr Med Chem 25(34):4269–4303
Biswas AK, Islam MR, Choudhury ZS, Mostafa A, Kadir MF (2014) Nanotechnology based approaches in cancer therapeutics. Adv Nat Sci Nanosci Nanotechnol 5(4):043001
Calzoni E, Cesaretti A, Polchi A, Di Michele A, Tancini B, Emiliani C (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10(1):4
Cho KJ, Wang X, Nie SM, Chen Z, Shin DM (2008) Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14(5):1310–1316
Chugh H, Sood D, Chandra I, Tomar V, Dhawan G, Chandra R (2018) Role of gold and silver nanoparticles in cancer nano-medicine. Artif Cells Nanomed Biotechnol 46:S1210–S1220
Contin M, Garcia C, Dobrecky C, Lucangioli S, D’Accorso N (2019) Advances in drug delivery, gene delivery and therapeutic agents based on dendritic materials. Future Med Chem 11(14):1791–1810
El-Say KM, El-Sawy HS (2017) Polymeric nanoparticles: promising platform for drug delivery. Int J Pharm 528(1–2):675–691
Farokhzad OC, Langer R (2009) Impact of nanotechnology on drug delivery. ACS Nano 3(1):16–20
Farooq MA, Aquib M, Farooq A, Khan DH, Maviah MBJ, Filli MS, Kesse S, Boakye-Yiadom KO, Mavlyanova R, Parveen A, Wang B (2019) Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artif Cells Nanomed Biotechnol 47(1):1674
Garcia-Pinel B, Porras-Alcala C, Ortega-Rodriguez A, Sarabia F, Prados J, Melguizo C, Lopez-Romero JM (2019) Lipid-based nanoparticles: application and recent advances in cancer treatment. Nano 9(4):638
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hauser-Kawaguchi AMN, Luyt LG (2015) Nanomedicine-nanoparticles in cancer imaging and therapy. In: Genomic instability and cancer metastasis: mechanisms, emerging themes, and novel therapeutic strategies, 20:205–244
He QJ, Gao Y, Zhang LX, Zhang ZW, Gao F, Ji XF, Li YP, Shi JL (2011) A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. Biomaterials 32(30):7711–7720
Ho BN, Pfeffer CM, Singh ATK (2017) Update on nanotechnology-based drug delivery systems in cancer treatment. Anticancer Res 37(11):5975–5981
Huang HC, Barua S, Sharma G, Dey SK, Rege K (2011) Inorganic nanoparticles for cancer imaging and therapy. J Control Release 155(3):344–357
Huang Y, Fan CQ, Dong H, Wang SM, Yang XC, Yang SM (2017) Current applications and future prospects of nanomaterials in tumor therapy. Int J Nanomedicine 12:1815–1825
Jain KK (2010) Advances in the field of nanooncology. BMC Med 8:83
Jain K, Jain NK (2014) Surface engineered dendrimers as antiangiogenic agent and carrier for anticancer drug: dual attack on cancer. J Nanosci Nanotechnol 14(7):5075–5087
Karanth H, Murthy RSR (2007) pH-sensitive liposomes - principle and application in cancer therapy. J Pharm Pharmacol 59(4):469–483
Kleinstreuer C, Childress E, Kennedy A (2013) Targeted drug delivery: multifunctional nanoparticles and direct micro-drug delivery to tumors. Transp Biol Media 30:391–416
Kneidl B, Peller M, Winter G, Lindner LH, Hossann M (2014) Thermosensitive liposomal drug delivery systems: state of the art review. Int J Nanomedicine 9:4387–4398
Li YA, Zhang H (2019) Nanoparticle-based drug delivery systems for enhanced tumor-targeting treatment. J Biomed Nanotechnol 15(1):1–27
Li Z, Tan SR, Li S, Shen Q, Wang KH (2017) Cancer drug delivery in the nano era: an overview and perspectives (review). Oncol Rep 38(2):611–624
Liang C, Diao S, Wang C, Gong H, Liu T, Hong GS, Shi XZ, Dai HJ, Liu Z (2014) Tumor metastasis inhibition by imaging-guided photothermal therapy with single-walled carbon nanotubes. Adv Mater 26(32):5646
Liao JF, Jia YP, Wu YZ, Shi K, Yang DW, Li P, Qian ZY (2019) Physical-, chemical-, and biological-responsive nanomedicine for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 12(1):e1581
Limeres MJ, Moretton MA, Bernabeu E, Chiappetta DA, Cuestas ML (2019) Thinking small, doing big: current success and future trends in drug delivery systems for improving cancer therapy with special focus on liver cancer. Mater Sci Eng C Mater Biol Appl 95:328–341
Lin TY, Zhang HY, Luo JT, Li YP, Gao TJ, Lara PN, White RD, Lam KS, Pan CX (2012) Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Int J Nanomedicine 7:2793–2804
Liu JZ, Dong J, Zhang T, Peng Q (2018) Graphene-based nanomaterials and their potentials in advanced drug delivery and cancer therapy. J Control Release 286:64–73
Maddela NR, Chakraborty S, Prasad R (2021) Nanotechnology for advances in medical microbiology. Springer Singapore (ISBN 978-981-15-9915-6) https://www.springer.com/gp/book/9789811599156
Martinez-Carmona M, Lozano D, Colilla M, Vallet-Regi M (2018) Lectin-conjugated pH-responsive mesoporous silica nanoparticles for targeted bone cancer treatment. Acta Biomater 65:393–404
Martinkova P, Brtnicky M, Kynicky J, Pohanka M (2018) Iron oxide nanoparticles: innovative tool in cancer diagnosis and therapy. Adv Healthc Mater 7(5):1700932
Mastrobattista E, Koning GA, Storm G (1999) Immunoliposomes for the targeted delivery of antitumor drugs. Adv Drug Deliv Rev 40(1–2):103–127
Navya PN, Kaphle A, Srinivas SP, Bhargava SK, Rotello VM, Daima HK (2019) Current trends and challenges in cancer management and therapy using designer nanomaterials. Nano Convergence 6:23
Niidome T, Yamagata M, Okamoto Y, Akiyama Y, Takahashi H, Kawano T, Katayama Y, Niidome Y (2006) PEG-modified gold nanorods with a stealth character for in vivo applications. J Control Release 114(3):343–347
Parveen S, Misra R, Sahoo SK (2017) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed Cancer 8(2):147–166
Prasad R, Pandey R, Barman I (2016) Engineering tailored nanoparticles with microbes: quo vadis. WIREs Nanomed Nanobiotechnol 8:316–330. https://doi.org/10.1002/wnan.1363
Prasad R, Pandey R, Varma A, Barman I (2017) Polymer based nanoparticles for drug delivery systems and cancer therapeutics. In: Kharkwal H, Janaswamy S (eds) Natural polymers for drug delivery. CAB International, London, pp 53–70
Prasad R, Siddhardha B, Dyavaiah M (2020) Nanostructures for antimicrobial and antibiofilm applications. Springer, New York. ISBN 978-3-030-40336-2. https://www.springer.com/gp/book/9783030403362
Safwat MA, Soliman GM, Sayed D, Attia MA (2018) Fluorouracil-loaded gold nanoparticles for the treatment of skin cancer: development, in vitro characterization, and in vivo evaluation in a mouse skin cancer xenograft model. Mol Pharm 15(6):2194–2205
Sevenson S, Tomalia DA (2012) Dendrimers in biomedical applications-reflections on the field. Adv Drug Deliv Rev 64:102–115
Sharma M, Pandey C, Sharma N, Kamal MA, Sayeed U, Akhtar S (2018) Cancer nanotechnology-an excursion on drug delivery systems. Anti Cancer Agents Med Chem 18(15):2078–2092
Shi XY, Wang SH, Meshinchi S, Van Antwerp ME, Bi XD, Lee IH, Baker JR (2007) Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 3(7):1245–1252
Shi SY, Liu YJ, Chen Y, Zhang ZH, Ding YS, Wu ZQ, Yin J, Nie LM (2016) Versatile pH-response micelles with high cell-penetrating helical Diblock copolymers for photoacoustic imaging guided synergistic chemo-photothermal therapy. Theranostics 6(12):2170–2182
Silva CO, Pinho JO, Lopes JM, Almeida AJ, Gaspar MM, Reis C (2019) Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics 11(1):22
Singh J, Jain K, Mehra NK, Jain NK (2016) Dendrimers in anticancer drug delivery: mechanism of interaction of drug and dendrimers. Artif Cells Nanomed Biotechnol 44(7):1626–1634
Sousa D, Ferreira D, Rodrigues JL, Rodrigues LR (2019) Nanotechnology in targeted drug delivery and therapeutics. In: Applications of targeted nano drugs and delivery systems: nanoscience and nanotechnology in drug delivery, Elsevier, pp 357–409
Steichen SD, Caldorera-Moore M, Peppas NA (2013) A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics. Eur J Pharm Sci 48(3):416–427
Steven A, Seliger B (2016) Control of CREB expression in tumors: from molecular mechanisms and signal transduction pathways to therapeutic target. Oncotarget 7(23):35454–35465
Suzuki R, Omata D, Oda Y, Unga J, Negishi Y, Maruyama K (2016) Cancer therapy with nanotechnology-based drug delivery systems: applications and challenges of liposome technologies for advanced cancer therapy. Nanomater Pharmacol 39:457–482
Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B (2019) Gold nanoparticles in cancer treatment. Mol Pharm 16(1):1–23
Thakor AS, Gambhir SS (2013) Nanooncology: the future of Cancer diagnosis and therapy. Cancer J Clin 63(6):395–418
Ulbrich K, Hola K, Subr V, Bakandritsos A, Tucek J, Zboril R (2016) Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116(9):5338–5431
Velez AMA, Howard MS (2015) Tumor-suppressor genes, cell cycle regulatory checkpoints, and the skin. N Am J Med Sci 7(5):176–188
Verma J, Lal S, Van Noorden CJF (2015) Inorganic nanoparticles for the theranostics of cancer. Eur J Nanomed 7(4):271–287
Wolinsky JB, Grinstaff MW (2008) Therapeutic and diagnostic applications of dendrimers for cancer treatment. Adv Drug Deliv Rev 60(9):1037–1055
Wu WC, Kuo YS, Cheng CH (2015a) Dual-stimuli responsive polymeric micelles: preparation, characterization, and controlled drug release. J Polym Res 22(5):80
Wu WD, Yi XL, Jiang LX, Li YZ, Gao J, Zeng Y, Yi RD, Dai LP, Li W, Ci XY, Si DY, Liu CX (2015b) The targeted-liposome delivery system of antitumor drugs. Curr Drug Metab 16(10):894–910
Xie LQ, Jin WW, Chen HL, Zhang QQ (2019) Superparamagnetic iron oxide nanoparticles for cancer diagnosis and therapy. J Biomed Nanotechnol 15(2):215–235
Xin Y, Huang Q, Tang JQ, Hou XY, Zhang P, Zhang LZ, Jiang G (2016) Nanoscale drug delivery for targeted chemotherapy. Cancer Lett 379(1):24–31
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Güven, E. (2021). Nanoparticles for Anticancer Drug Delivery. In: Saglam, N., Korkusuz, F., Prasad, R. (eds) Nanotechnology Applications in Health and Environmental Sciences. Nanotechnology in the Life Sciences. Springer, Cham. https://doi.org/10.1007/978-3-030-64410-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-030-64410-9_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-64409-3
Online ISBN: 978-3-030-64410-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)